Evidence map›Paper›PMID 31263268›Full record

ArticleNature cell biology2019

Phosphorylated Rho-GDP directly activates mTORC2 kinase towards AKT through dimerization with Ras-GTP to regulate cell migration.

Hiroshi Senoo, Yoichiro Kamimura, Reona Kimura, Akihiko Nakajima, Satoshi Sawai, Hiromi Sesaki, Miho Iijima

Open access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. The role of mTOR signaling in regulating the quality of mammalian oocytes.Journal of assisted reproduction and genetics · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Signaling and actin waves at a glance.Journal of cell science · 2025
    Review
  8. Review
  9. Loss of Lkb1 cooperates with BrafMolecular oncology · 2025
    Article
  10. Article
  11. Polyploidy and mTOR signaling: a possible molecular link.Cell communication and signaling : CCS · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. UsingCells · 2023
    Review
  17. Review
  18. Role of FLCN Phosphorylation in Insulin-Mediated mTORC1 Activation and Tumorigenesis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  19. Article
  20. ELMO1 Deficiency Reduces Neutrophil Chemotaxis in Murine Peritonitis.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Hiroshi SenooDepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Yoichiro KamimuraLaboratory for Cell Signaling Dynamics, Quantitative Biology Center, RIKEN, Suita, Japan.
Reona KimuraDepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Akihiko NakajimaDepartment of Basic Science, Graduate School of Arts and Sciences, University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0002-2690-6973
Satoshi SawaiDepartment of Basic Science, Graduate School of Arts and Sciences, University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-3764-219X
Hiromi SesakiDepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Miho IijimaDepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. miijima@jhmi.edu.ORCID http://orcid.org/0000-0002-3073-9135
Johns Hopkins University · USTokyo University of the Arts · JPRIKEN Center for Biosystems Dynamics Research · JP

Funding

Regulation of Intracellular SignalingR35GM131768 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Miho Iijima · 2019 to 2026
$4.0M
Lipid Signaling in ChemotaxisR01GM084015 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI IIJIMA, MIHO · 2009 to 2019
$2.9M
Mitochondrial Fusion and DivisionR01GM089853 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI SESAKI, HIROMI · 2010 to 2014
$2.1M
Mitochondrial Quality Control by Drp1R01GM123266 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI SESAKI, HIROMI · 2018 to 2021
$1.4M
NIGMS NIH HHS R01 GM084015NIGMS NIH HHS R01 GM089853NIGMS NIH HHS R01 GM123266NIGMS NIH HHS R35 GM131768
6 · The paper itself

Abstract

mTORC2 plays critical roles in metabolism, cell survival and actin cytoskeletal dynamics through the phosphorylation of AKT. Despite its importance to biology and medicine, it is unclear how mTORC2-mediated AKT phosphorylation is controlled. Here, we identify an unforeseen principle by which a GDP-bound form of the conserved small G protein Rho GTPase directly activates mTORC2 in AKT phosphorylation in social amoebae (Dictyostelium discoideum) cells. Using biochemical reconstitution with purified proteins, we demonstrate that Rho-GDP promotes AKT phosphorylation by assembling a supercomplex with Ras-GTP and mTORC2. This supercomplex formation is controlled by the chemoattractant-induced phosphorylation of Rho-GDP at S192 by GSK-3. Furthermore, Rho-GDP rescues defects in both mTORC2-mediated AKT phosphorylation and directed cell migration in Rho-null cells in a manner dependent on phosphorylation of S192. Thus, in contrast to the prevailing view that the GDP-bound forms of G proteins are inactive, our study reveals that mTORC2-AKT signalling is activated by Rho-GDP.

Indexed as

DimerizationAnimalsCell MovementCytoskeletonGlycogen Synthase Kinase 3GTP-Binding ProteinsGuanosine DiphosphateHumansMechanistic Target of Rapamycin Complex 2PhosphorylationProto-Oncogene Proteins c-aktGlycogen Synthase Kinase 3GTP-Binding ProteinsGuanosine DiphosphateMechanistic Target of Rapamycin Complex 2Proto-Oncogene Proteins c-akt

Identifiers

PMID31263268
PMCPMC6650273
OpenAlexW2955542032

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.